Skip to content

Examination of Cardiovascular Function/ Cardio Respiratory Interaction on Spontaneous Breathing Trials in Patients in the Prolonged Weaning

Examination of Cardiovascular Function/ Cardio Respiratory Interaction on Spontaneous Breathing Trials in Patients in the Prolonged Weaning

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02569385
Acronym
Weaning TTE
Enrollment
20
Registered
2015-10-06
Start date
2015-08-31
Completion date
2016-08-31
Last updated
2015-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease

Keywords

Weaning TTE, patients in prolonged weaning

Brief summary

The aim of the present study is to determine the cardiovascular function/ cardio respiratory interaction on spontaneous breathing trials in patients with prolonged weaning.

Interventions

OTHERSpontaneous breathing trial

Sponsors

RWTH Aachen University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* legal Age (≥18 years) * written informed consent Prior to study participation * patient in prolonged weaning with NYHA I-II and an actual positive Ventilator Screening test: 1. PaO2 ≥ 60 mmHg at FiO2 ≤ 0.4 2. PEEP ≤ 8 cmH2O 3. Glasgow Coma Scale \> 13 4. Temp. \< 38°C 5. Hb \> 80-100 g/L 6. less requirement on catecholamines (\<0.1µg/kg/min) * and on these patients are already performed a spontaneous breathing trial with following result: 1. abortion this spontaneous breathing trial \< 30min, but possible \> 10min 2. reason for an abortion was NOT hypercapnia

Exclusion criteria

* weaning patients are assigned on Group 1-2 * patient with heart failure (NYHA III-IV) and/ or other cardiac comorbidity * acute NSTEMI (non-ST-segment elevation myocardial infarction) * pregnancy and breast-feeding

Design outcomes

Primary

MeasureTime frameDescription
Baseline measurement (Modus CPAP-PS) in patient with prolonged weaning12 monthsunder pressure support Ventilation are determined some measurement (e.g. breathing rate)

Secondary

MeasureTime frameDescription
Intervention measurement in patient with prolonged weaning12 months20 min breathing without mechanical ventilation

Countries

Germany

Contacts

Primary ContactMichael Dreher, MD
mdreher@ukaachen.de+49 241 80 88763

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026